Citadel Advisors’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-110,550
Closed -$1.74M 7089
2024
Q1
$1.74M Sell
110,550
-150,738
-58% -$2.37M ﹤0.01% 2625
2023
Q4
$4.21M Buy
261,288
+26,264
+11% +$424K ﹤0.01% 1768
2023
Q3
$2.99M Buy
+235,024
New +$2.99M ﹤0.01% 2031
2023
Q2
Sell
-146,211
Closed -$2.26M 6666
2023
Q1
$2.26M Buy
146,211
+48,665
+50% +$752K ﹤0.01% 2436
2022
Q4
$1.6M Sell
97,546
-103,098
-51% -$1.69M ﹤0.01% 2774
2022
Q3
$3.71M Buy
200,644
+45,831
+30% +$848K ﹤0.01% 2132
2022
Q2
$2.04M Sell
154,813
-24,231
-14% -$319K ﹤0.01% 2718
2022
Q1
$1.66M Buy
179,044
+147,835
+474% +$1.37M ﹤0.01% 3216
2021
Q4
$305K Sell
31,209
-27,418
-47% -$268K ﹤0.01% 5099
2021
Q3
$1.99M Sell
58,627
-105,334
-64% -$3.58M ﹤0.01% 3010
2021
Q2
$6M Buy
163,961
+157,956
+2,630% +$5.78M ﹤0.01% 1949
2021
Q1
$269K Sell
6,005
-23,082
-79% -$1.03M ﹤0.01% 5143
2020
Q4
$1.66M Sell
29,087
-132,414
-82% -$7.56M ﹤0.01% 2761
2020
Q3
$8.29M Buy
161,501
+157,616
+4,057% +$8.09M ﹤0.01% 1212
2020
Q2
$232K Sell
3,885
-422,492
-99% -$25.2M ﹤0.01% 3977
2020
Q1
$17.6M Buy
426,377
+414,174
+3,394% +$17.1M 0.01% 714
2019
Q4
$760K Sell
12,203
-314,877
-96% -$19.6M ﹤0.01% 3239
2019
Q3
$11.1M Buy
327,080
+38,083
+13% +$1.29M 0.01% 1117
2019
Q2
$6.52M Sell
288,997
-76,019
-21% -$1.71M ﹤0.01% 1465
2019
Q1
$8.47M Sell
365,016
-172,427
-32% -$4M ﹤0.01% 1224
2018
Q4
$11.3M Buy
537,443
+221,981
+70% +$4.66M 0.01% 937
2018
Q3
$12.2M Buy
315,462
+287,991
+1,048% +$11.2M 0.01% 1001
2018
Q2
$1.08M Buy
27,471
+1,134
+4% +$44.6K ﹤0.01% 2593
2018
Q1
$528K Buy
+26,337
New +$528K ﹤0.01% 2873
2017
Q4
Sell
-261,436
Closed -$4.97M 4362
2017
Q3
$4.97M Buy
+261,436
New +$4.97M ﹤0.01% 1274